Acetone is not classified as a carcinogen by any major regulatory agency. The U.S. EPA has stated that data are “inadequate for an assessment of the human carcinogenic potential of acetone,” and the American Conference of Governmental Industrial Hygienists (ACGIH) categorizes it as A4, meaning “Not Classifiable as a Human Carcinogen.” Neither the International Agency for Research on Cancer (IARC) nor the U.S. Department of Health and Human Services has even evaluated acetone for carcinogenicity, largely because the available evidence has never raised a red flag.
What the Animal and Lab Studies Show
No long-term animal studies have found tumors linked to acetone exposure, whether through inhalation or ingestion. In skin-painting experiments where acetone was applied directly to mice as a control substance, there was no evidence it acted as a skin carcinogen. Separate studies tested whether acetone could initiate tumors or promote the growth of tumors started by a known carcinogen. It failed on both counts.
At the genetic level, acetone does not appear to damage DNA. Standard bacterial mutation tests (Ames tests) found it was not mutagenic, and chromosome studies in rats showed no significant increase in chromosomal damage at the concentrations tested. This matters because substances that cause cancer almost always damage DNA or disrupt how cells divide. Acetone does neither in the studies conducted so far.
Why the Classification Stops at “Inadequate Data”
You might wonder why agencies say data are “inadequate” rather than giving acetone a clean bill of health. The distinction is procedural. To formally declare a substance non-carcinogenic, agencies typically want a full set of rigorous, long-term studies designed specifically to test for cancer. Those dedicated lifetime bioassays, where large groups of animals are exposed and monitored for their entire lives, simply haven’t been conducted for acetone. The existing evidence points away from cancer risk, but the formal studies that would close the book haven’t been run.
The EPA’s assessment, last updated in 2003, reflects this gap. The ACGIH’s A4 designation essentially says the same thing: the evidence doesn’t support calling it a carcinogen, but it also doesn’t meet the bar for declaring it definitively safe in regulatory terms.
Your Body Already Makes Acetone
One reason acetone gets less scrutiny than many industrial chemicals is that your body produces it naturally. It’s a normal byproduct of fat metabolism. When your liver breaks down fatty acids, it generates ketone bodies, and acetone is one of them. Healthy people exhale roughly 0.5 to 2.0 parts per million of acetone in their breath at any given time. During fasting, dieting, or uncontrolled diabetes, those levels rise significantly.
Your body also has an efficient system for clearing acetone. A liver enzyme converts acetone into intermediates that feed into the pathway your body uses to make glucose. Studies in mice that lack this enzyme showed a 28-fold increase in blood acetone levels after fasting, compared to only a 2.5 to 4.4-fold increase in normal mice. In other words, the enzyme keeps acetone from building up, and in healthy people this system works continuously.
Health Risks That Aren’t Cancer
The fact that acetone isn’t a carcinogen doesn’t mean it’s harmless. At high concentrations, it irritates the eyes, nose, and throat. It’s a central nervous system depressant, so heavy exposure causes headaches, dizziness, confusion, and at extreme levels, loss of consciousness. These effects are most relevant to people who work with acetone in poorly ventilated spaces or who inhale it intentionally.
Animal studies on chronic exposure have found kidney damage, liver damage, nerve damage, birth defects, and male infertility. Whether these specific effects occur in humans at similar exposure levels isn’t well established, but they’re the reason workplace exposure limits exist.
Workplace Exposure Limits
OSHA sets a permissible exposure limit of 1,000 ppm averaged over an eight-hour workday, with a short-term ceiling of 3,000 ppm. NIOSH recommends a more conservative limit of 250 ppm over eight hours, and the ACGIH matches that at 250 ppm with a short-term limit of 500 ppm. These limits are designed to prevent the neurological and irritation effects of acetone, not cancer risk.
For most people, exposure comes from nail polish remover, paint thinners, adhesives, or cleaning products. Brief, occasional use in a ventilated room keeps exposure well below occupational limits. The people most likely to approach those thresholds are workers in manufacturing, auto body shops, or laboratories who handle acetone daily.